BRAF and neoplasm: Thus, we can hypothesize that, while screening methods might be sufficient to detect all BRAF mutations in the presence of adequate percentage of tumour cells in a given sample, a combined approach with Cast-PCR would efficiently overcome the melanin content and tumour heterogeneity issues and guarantee a better genotypization of the patients.